Search

everythinglearnresearchcommunity

for

Search:↓

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Compound 7p shows strong potential as an anticancer agent.

Optimized formulations with specific ingredients can significantly improve skin delivery of topical drugs.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Lower SMAD2/3 activation predicts more severe skin cancer.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Isotretinoin and tazarotene help treat acne, while minoxidil and finasteride promote hair growth.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

DiluCap improves how quickly minoxidil and finasteride dissolve and controls the release of melatonin and naltrexone.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Peficitinib can turn human fibroblasts into cells that help grow hair.

The new minoxidil gel improves hair growth and reduces skin irritation.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.